188 related articles for article (PubMed ID: 37119562)
1. Psychotropic drugs consumption during 2020 COVID-19 pandemic and lockdowns: Evidence of a surprising resilience of the drugs delivery system in France.
Laurin A; Bulteau S; Caillet P; Artari P; Sauvaget A; Gollier-Briant F; Huon JF; Bonnot O
Eur Neuropsychopharmacol; 2023 Aug; 73():48-61. PubMed ID: 37119562
[TBL] [Abstract][Full Text] [Related]
2. Trends in psychotropic drug consumption among French military personnel during the COVID-19 epidemic.
Sanchez MA; Fuchs B; Tubert-Bitter P; Mariet AS; Jollant F; Mayet A; Quantin C
BMC Med; 2022 Sep; 20(1):306. PubMed ID: 36100914
[TBL] [Abstract][Full Text] [Related]
3. Substance use during the COVID-19 pandemic: What is really happening?
Mellos E; Paparrigopoulos T
Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
[TBL] [Abstract][Full Text] [Related]
4. Patterns of psychotropic drug prescriptions and general practice consultations among community-dwelling older people with dementia during the first two years of the COVID-19 pandemic.
Du J; Burger H; Kupers T; Sulim K; Homburg MT; Muris JWM; Olde Hartman TC; Zuidema SU; Peters LL; Janus SIM
BMC Geriatr; 2024 Feb; 24(1):120. PubMed ID: 38297202
[TBL] [Abstract][Full Text] [Related]
5. Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 Pandemic.
Valtuille Z; Acquaviva E; Trebossen V; Ouldali N; Bourmaud A; Sclison S; Gomez A; Revet A; Peyre H; Delorme R; Kaguelidou F
JAMA Netw Open; 2024 Apr; 7(4):e247965. PubMed ID: 38652474
[TBL] [Abstract][Full Text] [Related]
6. A Qualitative Study of Autistic Adults' Quality of Life During the COVID-19 Pandemic and Lockdowns.
Stewart GR; Leoni M; Charlton RA; Pickard HR; Happé F
Autism Adulthood; 2023 Sep; 5(3):311-324. PubMed ID: 37663440
[TBL] [Abstract][Full Text] [Related]
7. Impact of COVID-19 pandemic and lockdowns on the consumption of anxiolytics, hypnotics and antidepressants according to age groups: a French nationwide study.
Levaillant M; Wathelet M; Lamer A; Riquin E; Gohier B; Hamel-Broza JF
Psychol Med; 2023 May; 53(7):2861-2867. PubMed ID: 34904556
[TBL] [Abstract][Full Text] [Related]
8. Mental and physical health among the French population before and during the first and second COVID-19 lockdowns: Latent class trajectory analyses using longitudinal data.
Lu L; Contrand B; Dupuy M; Ramiz L; Sztal-Kutas C; Lagarde E
J Affect Disord; 2022 Jul; 309():95-104. PubMed ID: 35452759
[TBL] [Abstract][Full Text] [Related]
9. General hospital admissions in young and middle-aged people who use psychoactive substances: Impact of Covid-19 lockdowns.
Perino J; Ramaroson H; Ong N; Bezin J; Gilleron V; Daveluy A; Tournier M
Int J Drug Policy; 2023 Aug; 118():104082. PubMed ID: 37336071
[TBL] [Abstract][Full Text] [Related]
10. [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
Javelot H; Llorca PM; Drapier D; Fakra E; Hingray C; Meyer G; Dizet S; Egron A; Straczek C; Roser M; Masson M; Gaillard R; Fossati P; Haffen E
Encephale; 2020 Jun; 46(3S):S14-S34. PubMed ID: 32376004
[TBL] [Abstract][Full Text] [Related]
11. Predictors of mental well-being over the first lockdown period due to the COVID-19 pandemic in France. A repeated cross-sectional study.
Barbalat G; Tanguy Melac A; Zante E; Haesebaert F; Franck N
Front Public Health; 2023; 11():1234023. PubMed ID: 37701911
[TBL] [Abstract][Full Text] [Related]
12. Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study.
Mathieu C; Pambrun E; Bénard-Laribière A; Noize P; Faillie JL; Bezin J; Pariente A
Eur J Epidemiol; 2022 Oct; 37(10):1049-1059. PubMed ID: 36129659
[TBL] [Abstract][Full Text] [Related]
13. Reactive surveillance of suicides during the COVID-19 pandemic in France, 2020 to March 2022.
Fouillet A; Martin D; Pontais I; Caserio-Schönemann C; Rey G
Epidemiol Psychiatr Sci; 2023 Apr; 32():e20. PubMed ID: 37066804
[TBL] [Abstract][Full Text] [Related]
14. Evolution of the profiles of new psychotropic drug users before and during the COVID-19 crisis: an original longitudinal approach through multichannel sequence analysis using the French health-care database.
Istvan M; Duval M; Hodel K; Aquizerate A; Chaslerie A; Artarit P; Laforgue EJ; Victorri-Vigneau C
Eur Arch Psychiatry Clin Neurosci; 2024 Mar; ():. PubMed ID: 38499795
[TBL] [Abstract][Full Text] [Related]
15. Remote harm reduction services are key solutions to reduce the impact of COVID-19-like crises on people who use drugs: evidence from two independent structures in France and in the USA.
Torres-Leguizamon M; Favaro J; Coello D; Reynaud EG; Néfau T; Duplessy C
Harm Reduct J; 2023 Jan; 20(1):1. PubMed ID: 36611167
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic Medication Use and Psychiatric Disorders During the COVID-19 Pandemic Among Danish Children, Adolescents, and Young Adults.
Bliddal M; Rasmussen L; Andersen JH; Jensen PB; Pottegård A; Munk-Olsen T; Kildegaard H; Wesselhoeft R
JAMA Psychiatry; 2023 Feb; 80(2):176-180. PubMed ID: 36515919
[TBL] [Abstract][Full Text] [Related]
17. Psychotropic consumption before and during COVID-19 in Asturias, Spain.
García MLN; Martínez PF; Bretón EF; Martínez Alfonso MM; Gil PS
BMC Public Health; 2023 Mar; 23(1):494. PubMed ID: 36918825
[TBL] [Abstract][Full Text] [Related]
18. The impact of the COVID-19 Pandemic on the Greek population: Suicidal ideation during the first and second lockdown.
Gournellis R; Efstathiou V
Psychiatriki; 2021 Dec; 32(4):267-270. PubMed ID: 34860683
[TBL] [Abstract][Full Text] [Related]
19. [Mental health care in French correctional facilities during the Covid-19 pandemic].
Fovet T; Lancelevée C; Eck M; Scouflaire T; Bécache E; Dandelot D; Giravalli P; Guillard A; Horrach P; Lacambre M; Lefebvre T; Moncany AH; Touitou D; David M; Thomas P
Encephale; 2020 Jun; 46(3S):S60-S65. PubMed ID: 32475693
[TBL] [Abstract][Full Text] [Related]
20. Perceptions of Covid-19 lockdowns and related public health measures in Austria: a longitudinal online survey.
Łaszewska A; Helter T; Simon J
BMC Public Health; 2021 Aug; 21(1):1502. PubMed ID: 34344343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
